Charité Universitätsmedizin Berlin
Berlin, Germany
Clinician scientist in Nephrology, determined to understand AKI-to-CKD transition via scRNA-seq
Monday, November 13, 2023
8:30 AM – 8:50 AM PT
Disclosure(s): AstraZeneca: Ownership Interest (Ongoing); Bayer: Ownership Interest (Ongoing); BioNTech: Ownership Interest (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); CureVac: Ownership Interest (Ongoing); Linde: Ownership Interest (Ongoing); Moderna: Ownership Interest (Ongoing); Pfizer: Ownership Interest (Ongoing)